Graeme Sloan – Managing Director – Kali Metals (ASX:KM1) is a portfolio of assets that represents one of the largest and most prospective exploration packages across Australia’s world leading hard-rock lithium fields.
Copyright 2024 – Finance News Network
18 May 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari provides an update on the company's pipeline and discusses the recent licensing of an asset from UCLA.
22 May 2023 - Kalamazoo Resources Limited (ASX:KZR) CEO and Chairman Luke Reinehr discusses plans to spin out the company's lithium projects into a new ASX-listed exploration company in an agreement with TSX-listed Canadian gold miner Karora Resources.
06 Sep 2024 - Bernie Fernandes, State Manager (WA & SA) of Sequoia Financial Group (ASX:SEQ), talks with CEO and Managing Director Garry Crole. Bernie shares insights for advisors from his long career.
03 Sep 2020 - Hazer Group (ASX:HZR) CEO & Managing Director, Geoff Ward talks about FY20 achievements, its final investment decision for its Commercial Development Plant to process low emissions hydrogen gas and high purity graphite production from biogas, development and commercial programs.
25 Jul 2024 - Alex Dorsch - CEO & Managing Director - Chalice Mining (ASX:CHN) is advancing the Gonneville Project—a major 2020 discovery in Western Australia with critical metals like platinum, nickel, and copper—towards development. The project boasts a tier-1 Mineral Resource Estimate, significant land in the new West Yilgarn Ni-Cu-PGE Province, and has earned multiple awards, including the 2023 Thayer Lindsley Award.
10 Oct 2023 - Dr Mike Jones - Managing Director - Impact Minerals (ASX:IPT) is an exploration company listed on the ASX in November 2006. The Company manages extensive tenement holdings (>4,000 km2) within Australia featuring significant potential for high-grade mineral deposits of gold, silver, lead, zinc, copper, nickel and PGM’s.
11 Aug 2020 - Regeneus (ASX:RGS) CEO, Leo Lee talks about its collaboration with Kyocera of Japan to market Progenza its cell therapy treatment for anti-inflammatory treatment and repair of damaged or diseased tissue.
13 Feb 2020 - Centuria Capital Group (ASX:CNI) Joint CEO, John McBain talks 1H20 results & outlook, including the contribution from recent acquisitions as group AUM now exceeds $7.3B.